May 17, 2022, 15:24 by

With this investment, Biofourmis plans to scale up its virtual care offerings. This includes delivering personalized and predictive in-home care to a growing number of acutely ill patients and expanding its recently announced virtual specialty care services, Biofourmis Care, to those patients with complex chronic conditions. In parallel, Biofourmis plans to fund clinical trials to advance the development of digital therapies that work in conjunction with high-value drugs to improve efficacy, while forming strategic partnerships with companies in the digital health and virtual-first care ecosystems.

May 17, 2022, 15:24 by

May 17, 2022, 15:24 by

PPMI is designed to identify biological markers and clinical changes associated with Parkinson’s disease risk, onset, and progression.

May 17, 2022, 15:24 by

May 17, 2022, 15:24 by

May 17, 2022, 15:24 by

BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences.

May 17, 2022, 15:24 by

As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.

May 17, 2022, 15:24 by

BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.

May 17, 2022, 15:24 by

May 17, 2022, 15:24 by

The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel, has just won the Society for Clinical Trial’s annual Trial of the Year Award for 2021.

May 17, 2022, 15:24 by

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.

May 17, 2022, 01:00 by User Not Found

Clinical Research News | The clinical research situation in Ukraine has changed from “peaceful, predictable, and promising” a year ago to “complex, complicated, and difficult” since the Feb. 24 Russian invasion, according to Serhiy Mykhaylov, Merck’s clinical research director in the country speaking during a recent DIA webinar on the ethical dilemmas the war has created for those supporting study participants in the region. As of six months ago, Ukraine had 500 active ongoing studies.

May 11, 2022, 01:00 by User Not Found

Clinical Research News | A pioneering program of Geisinger Health System has returned clinically actionable results from exome sequencing to a record-breaking 3,400 individuals at increased risk for potentially life-threatening conditions such as hereditary breast and colon cancers, familial hypercholesterolemia (FH), and heart disease. The MyCode Community Health Initiative, enabled by a 2014 agreement with Regeneron Pharmaceuticals, draws from participants in a sizable DNA biobank who agree to the sequencing and results reporting.

May 10, 2022, 01:00 by User Not Found

Clinical Research News | Evidence is emerging that cerebrospinal fluid (CSF) testing might be useful in clinical settings for monitoring tumor growth and treatment response in pediatric patients with diffuse midline glioma (DMG), a lethal high-grade brain tumor that is inoperable and unlikely to be cured. Only about 500 new cases get diagnosed in the U.S. in any given year, but over two-thirds of them carry the exact same mutation (H3 K27M) allowing development of an assay that analyzes cell-free tumor DNA samples using digital droplet polymerase chain reaction (ddPCR).

May 6, 2022, 01:00 by User Not Found

Clinical Research News | Accurate information is the foundation of any quality research study, particularly when the study is decentralized or takes a hybrid approach. For decentralized clinical trials (DCTs), the appropriate selection of healthcare practitioners is all the more important to ensure patient care and data integrity.

May 3, 2022, 08:00 by User Not Found

Clinical Research News | Ken Getz and host Deborah Borfitz explore patient engagement for the newest episode of the Scope of Things podcast. Getz, Executive Director & Research Professor at the Tufts Center for the Study of Drug Development (CSDD), shares what his research has revealed about how patient engagement efforts are progressing, where we’re stuck in a rut, and a crucial misalignment in the industry’s view of patient engagement and what clinical research participants actually want.

Apr 29, 2022, 01:00 by User Not Found

Clinical Research News | Funding for digital twin use in clinical trials, immune-oncology cancer therapeutics, and virtual care and digital medicine, and more.

Apr 28, 2022, 01:00 by User Not Found

Clinical Research News | AI and ML in clinical trials, patent for minimum residual tumor detection, T-cell receptor engineering for cancer treatment, award given for COVID-19 clinical trial activities, synthetic control arms and decentralized trials, and more.

Apr 25, 2022, 17:17 by

[url=https://www.reg.ru/?rlink=reflink-7347627] Domain registration [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] hosting [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] sites on wordpress [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] cloud vps [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] ssl certificates [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] servers [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] dc [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] data centers[/url] ...

Apr 25, 2022, 17:17 by

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.